These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4365758)

  • 1. Effects of epinephrine, adrenocorticotrophic hormone, and theophylline on adenosine 3', 5'-monophosphate phosphodiesterase activity in fat cells.
    Pawlson LG; Lovell-Smith CJ; Manganiello VC; Vaughan M
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1639-42. PubMed ID: 4365758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of basal and hormone-stimulated adenylate cyclase in adipocyte ghosts by the prostaglandin endoperoxide prostaglandin H2.
    Gorman RR; Hamberg M; Samuelsson B
    J Biol Chem; 1975 Aug; 250(16):6460-3. PubMed ID: 169245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells.
    Manganiello VC; Murad F; Vaughan M
    J Biol Chem; 1971 Apr; 246(7):2195-202. PubMed ID: 4324562
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin action on adenylate cyclase. The effect of insulin on adenylate cyclase of rat fat cells in the presence of theophylline].
    Honda H
    Nihon Naibunpi Gakkai Zasshi; 1982 Sep; 58(9):1067-79. PubMed ID: 6293896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal control of fat cells adenylate cyclase.
    Harris R; Bennun A
    Mol Cell Biochem; 1976 Dec; 13(3):141-6. PubMed ID: 187930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterases and thyroid hormones.
    Van Inwegen RG; Robison GA; Thompson WJ
    J Biol Chem; 1975 Apr; 250(7):2452-6. PubMed ID: 164441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells.
    Allen DO; Clark JF; Ashmore J
    J Pharmacol Exp Ther; 1973 May; 185(2):379-85. PubMed ID: 4350040
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin.
    Illiano G; Cuatrecasas P
    Science; 1972 Feb; 175(4024):906-8. PubMed ID: 4332823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat pancreatic adenylate cyclase. IV. Effect of hormones and other agents on cyclic AMP level and enzyme release.
    Kempen JM; De Pont JJ; Bonting SL
    Biochim Biophys Acta; 1977 Jan; 496(1):65-76. PubMed ID: 189833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of epinephrine-induced increase in liver cyclic AMP by endogeneous insulin in vivo.
    Shikama H; Ui M
    Biochim Biophys Acta; 1976 Sep; 444(2):461-71. PubMed ID: 183827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone.
    Elks ML; Manganiello VC; Vaughan M
    J Biol Chem; 1983 Jul; 258(14):8582-7. PubMed ID: 6190811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine deaminase on cyclic adenosine monophosphate accumulation, lipolysis, and glucose metabolism of fat cells.
    Fain JN; Wieser PB
    J Biol Chem; 1975 Feb; 250(3):1027-34. PubMed ID: 164437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular levels of feedback regulator of adenylate cyclase and the effect of epinephrine and insulin.
    Ho Rj; Russell TR; Asakawa T; Sutherland EW
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4739-43. PubMed ID: 174073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of epinephrine and insulin on phosphopeptide metabolism in adipocytes.
    Avruch J; Leone GR; Martin DB
    J Biol Chem; 1976 Mar; 251(5):1511-5. PubMed ID: 176155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-dependent lipolysis in fat-cells from thyroidectomized rats.
    Correze C; Laudat MH; Laudat P; Nunez J
    Mol Cell Endocrinol; 1974 Oct; 1(5):309-27. PubMed ID: 4375635
    [No Abstract]   [Full Text] [Related]  

  • 16. The absence of stimulation of lipolysis by papaverine, a strong inhibitor of phosphodiesterase.
    Hynie S; Wenke M
    Eur J Pharmacol; 1975 Feb; 30(2):230-7. PubMed ID: 165081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.
    Manganiello V; Vaughan M
    J Clin Invest; 1972 Oct; 51(10):2763-7. PubMed ID: 4341439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal control of cyclic 3':5'-AMP levels and gluconeogenesis in isolated hepatocytes from fed rats.
    Pilkis SJ; Claus TH; Johnson RA; Park CR
    J Biol Chem; 1975 Aug; 250(16):6328-36. PubMed ID: 169237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificity of adenyl cyclase from rat fat cell ghosts.
    Bär HP; Hechter O
    Biochim Biophys Acta; 1969 Oct; 192(1):141-4. PubMed ID: 4310531
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells.
    Butcher RW; Baird CE; Sutherland EW
    J Biol Chem; 1968 Apr; 243(8):1705-12. PubMed ID: 4384670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.